Testing effectiveness (Phase 2)Looking for participantsNCT06305286
What this trial is testing
Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)
Who this might be right for
Type 1 Diabetes Mellitus
University of Chicago 70